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Saccharomyces cerevisiae Grx6 and Grx7 are two monothiol glutaredoxins whose active-site sequences (CSYS
and CPYS, respectively) are reminiscent of the CPYC active-site sequence of classical dithiol glutaredoxins.
Both proteins contain an N-terminal transmembrane domain which is responsible for their association to
membranes of the early secretory pathway vesicles, facing the luminal side. Thus, Grx6 localizes at the
endoplasmic reticulum and Golgi compartments, while Grx7 is mostly at the Golgi. Expression of GRX6 is
modestly upregulated by several stresses (calcium, sodium, and peroxides) in a manner dependent on the
Crz1-calcineurin pathway. Some of these stresses also upregulate GRX7 expression under the control of the
Msn2/4 transcription factor. The N glycosylation inhibitor tunicamycin induces the expression of both genes
along with protein accumulation. Mutants lacking both glutaredoxins display reduced sensitivity to tunica-
mycin, although the drug is still able to manifest its inhibitory effect on a reporter glycoprotein. Grx6 and Grx7
have measurable oxidoreductase activity in vivo, which is increased in the presence of tunicamycin. Both
glutaredoxins could be responsible for the regulation of the sulfhydryl oxidative state at the oxidant conditions
of the early secretory pathway vesicles. However, the differences in location and expression responses against
stresses suggest that their functions are not totally overlapping.
Glutaredoxins (Grxs) are thiol oxidoreductases that catalyze
the reduction of intra- and intermolecular disulfides using re-
duced glutathione (GSH) as the electron donor (29). They
carry out a variety of physiological functions (reviewed in ref-
erences 19 and 28), which include ribonucleotide reductase
and 3-phosphoadenylylsulfate reductase activation, ascorbate
reduction, and regulation of the DNA binding activity of nu-
clear factors, among others. Classical (dithiol) Grxs contain a
CPY/FC active-site motif, and they operate through a mecha-
nism of action that involves both cysteine residues for reducing
protein disulfides. However, only the most N-terminal cysteine
of the active site is required for deglutathionylation of mixed
disulfides between glutathione and protein cysteines (6). Di-
thiol Grx activity is usually measured through its ability to
reduce the mixed disulfide formed between GSH and one
mercaptoethanol moiety of the -hydroxyethyl disulfide (HEDS)
substrate (29). More recently, another Grx subfamily containing
the active-site CGFS motif has been described. For this
reason, they have been named monothiol Grxs (reviewed in
reference 28). Monothiol Grxs do not display activity in the
HEDS assay, and members of this subfamily are present in
organisms from prokaryotes to higher eukaryotes. In addi-
tion, plants may have other Grx subfamilies with conserved
motifs different from those characteristic of the dithiol and
monothiol Grxs (56).
Saccharomyces cerevisiae provides an example of the diver-
sity of locations and functions for Grxs. This yeast contains two
dithiol Grxs (Grx1 and Grx2), which are cytosolic (38), but a
minor part of Grx2 is also present in mitochondria (51). The
physiological function of Grx1 and Grx2 is not clearly estab-
lished, although yeast cells show some hypersensitivity to oxi-
dants in their absence (13, 38). In addition, S. cerevisiae has
three monothiol Grxs (54). Two of them (Grx3 and Grx4) are
nucleocytoplasmic (37, 43) and are involved in iron homeosta-
sis, probably through the regulation of the location of Aft1,
which is a transcription factor controlling the expression of
genes implicated in the assimilation of iron in yeast cells (48,
52). The third monothiol Grx (Grx5) is at the mitochondrial
matrix and participates in the synthesis of Fe/S clusters (35, 45,
55). In eukaryotic microorganisms and animals, synthesis of
Fe/S clusters occurs mainly, if not exclusively, in mitochondria,
while plant chloroplasts also contain machinery for Fe/S bio-
genesis (45). Homologues of Grx5 from bacteria (44), zebra
fish (68), humans (44), and plants (10) can substitute for native
Grx5 in the Fe/S synthesis function in yeast cells, supporting
the functional conservation of Grx5 along the course of evo-
lution. In accordance with this, the absence of Grx5 function in
zebra fish and human cells results in pathologies associated
with iron metabolism alterations (7, 68).
Some dithiol Grx molecules themselves may contain Fe/S
clusters required for enzyme structure and activity. This is the
case of human Grx2 (3, 32, 36) and poplar Grx C1 (57). Human
Grx2 may act as a sensor of oxidative stress conditions through
its Fe/S clusters, which would have a structural role (36). Sev-
eral CGFS-type monothiol Grxs also contain Fe/S clusters, at
least when purified from bacterial cells (50), although in vivo
studies are required to confirm the physiological significance of
these observations.
Recently, two additional Grxs in S. cerevisiae, named Grx6
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and Grx7, have been described (39, 40). They contain CSYS
and CPYS motifs, respectively, at their active sites. Therefore,
they should be also defined as monothiol Grxs, although the
primary sequences of their Grx modules are more similar to
those of dithiol Grxs than to those of monothiol Grxs of the
CGFS type (39, 40). In contrast to the latter, both Grx6 and
Grx7 are active in the HEDS assay and, when purified from
bacteria, Grx6 (but not Grx7) binds two Fe/S clusters which are
required for tetramer formation. Detailed analysis of their
primary sequences indicates that Grx6 and Grx7 contain a
putative transmembrane (TM) domain at their N-terminal
ends. This suggests that both of them may be membrane-
associated Grxs and that their functions may be related to
redox regulation in the oxidant conditions occurring in the
secretory machinery compartments (8, 64). In this study, we
describe the cellular location of Grx6 and Grx7, demonstrate
their in vivo activity as Grxs, analyze their expression in differ-
ent physiological conditions, and provide some evidence as to
their possible functions. The results demonstrate that although
Grx6 and Grx7 display significant structural and biochemical
similarities, some differences exist between them concerning
cellular location, responses to stresses, and posttranslational
modifications.
MATERIALS AND METHODS
Strains and growth conditions. The S. cerevisiae strains employed in this work
are described in Table 1. Cells were grown at 30°C unless stated otherwise, using
yeast extract-peptone-dextrose (YEPD) medium (1% yeast extract, 2% peptone,
2% glucose) or SC medium (0.67% yeast nitrogen base, 2% glucose plus dropout
mixture and auxotrophic requirements [60]). Specific supplements were omitted
for selection of the corresponding plasmid-carrying cells. Cells were grown ex-
ponentially for at least 10 generations before samples were taken for analyses.
Plasmid and strain construction. Plasmids pMM799 and pMM881 are S.
cerevisiae URA3 integrative plasmids derived from YIplac211 (23), which con-
tain, respectively, the GRX6 and GRX7 genes tagged at their 3 ends with the
3HA epitope sequence plus 814 (GRX6) or 750 (GRX7) nucleotides upstream
from the respective translation initiation sites. Plasmid pMM894 derives from
pMM799 by deletion from codon 3 to codon 40 (inclusive) of the GRX6 coding
region. Deletion was made using the ExSite method (67). Similarly, plasmid
pMM896 derives from pMM881 by deletion from codon 3 to codon 36 of the
GRX7 coding region. Plasmids pMM892 (centromeric; URA3) and pMM866
(episomal; URA3) derive from YCplac33 and YEplac195, respectively (23), and
contain a 3HA-tagged GRX6 sequence with its own promoter region (as for
pMM799). Plasmid pMM880 was obtained from pMM866 by mutating the codon
for the C136 residue in GRX6 for a serine codon by use of the ExSite method.
TABLE 1. Strains used in this work
Strain Relevant genotype Comment(s)
W303-1A MATa ura3-1 ade2-1 leu2-3,112 trp1-1 his3-11,15 Wild type
W303-1B MAT ura3-1 ade2-1 leu2-3,112 trp1-1 his3-11,15 Wild type
Wmsn2msn4 W303-1A msn2::HIS3 msn4::TRP1 From F. Estruch
MML752 W303-1A grx1::kanMX4 grx2::LEU2 Reference 21
MML866 W303-1B grx7::kanMX4 GRX7 disruption with kanMX4 cassette
MML871 W303-1A crz1::kanMX4 Deletion region moved from BY4741; crz1::kanMX4
MML887 W303-1A grx7::kanMX4 GRX7 disruption with kanMX4 cassette
MML890 W303-1A grx6::CaURA3 GRX6 disruption with CaURA3 cassette
MML892 W303-1A grx6::CaURA3 grx7::kanMX4 From a cross, MML866  MML890
MML897 W303-1A pMM799(GRX6-3HA)::URA3 Integration of pMM799 in W303-1A
MML949 W303-1A GRX7-3HA::hphNT1 Chromosomal GRX7 tagged with 3HA using the
hphNT1 cassette
MML953 W303-1A GRX6-3HA::hphNT1 Chromosomal GRX6 tagged with 3HA using the
hphNT1 cassette
MML999 W303-1A pMM881(GRX7-3HA)::URA3 Integration of pMM881 in W303-1A
MML1001 W303-1A pMM799(GRX6-3HA)::URA3 OLE1::GFP OLE1::GFP construction moved from CYC243
(Verge´s et al., 2007 65) into MML897
MML1003 W303-1A pMM881(GRX7-3HA)::URA3 OLE1::GFP OLE1::GFP construction moved from CYC243 into
MML999
MML1005 W303-1A; OLE1::GFP into W303-1A OLE1::GFP construction moved from CYC243
MML1037 W303-1A pMM894(GRX6D3/40-3HA)::URA3 Integration of pMM894 in W303-1A
MML1039 W303-1A pMM896(GRX7D3/36-3HA)::URA3 Integration of pMM896 in W303-1A
CML128 MATa ura3-52 leu2-3,112 trp1-1 his4 Wild type; reference 20
CYC209 CML128 tTA-LEU2 KAR2-6FLAG-kanMX4 Reference 33, from M. Aldea
CYC211 CML128 tTA-LEU2 SEC62-6FLAG-kanMX4 Reference 33, from M. Aldea
MML1011 CYC209 KAR2-6FLAG-kanMX4 pMM881(GRX7-3HA)::URA3 Integration of pMM881 into CYC209
MML1012 CYC211 SEC62-6FLAG-kanMX4
pMM881(GRX7-3HA)::URA3
Integration of pMM881 into CYC211
MML1013 CYC209 KAR2-6FLAG-kanMX4 pMM799(GRX6-3HA)::URA3 Integration of pMM799 into CYC209
MML1014 CYC211 SEC62-6FLAG-kanMX4
pMM799(GRX6-3HA)::URA3
Integration of pMM799 into CYC211
BY4741 MATa his3D1 leu2D0 met15D0 ura3D0 Wild type
Y03792 BY4741 pmt1::kanMX4 From Euroscarf, deletion of PMT1
Y00385 BY4741 pmt2::kanMX4 From Euroscarf, deletion of PMT2
Y01618 BY4741 pmt3::kanMX4 From Euroscarf, deletion of PMT3
Y03790 BY4741 pmt5::kanMX4 From Euroscarf, deletion of PMT5
Y04829 BY4741 pmt6::kanMX4 From Euroscarf, deletion of PMT6
AN1-7D MAT ura3-52 trp1 leu2-3,112 sec18ts Reference 47
MML1010 AN1-7D pMM799 (GRX6-3HA)::URA3 Integration of pMM799 into AN1-7D
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Plasmid pMM822 is a YEplac195 derivative which contains the GRX6 open
reading frame plus 814 nucleotides of the promoter region and 284 nucleotides
downstream of the stop codon. Similarly, pMM763 derives from YEplac195 and
contains the GRX7 coding sequence plus 750 upstream and 364 downstream
nucleotides.
Standard protocols were used for DNA manipulations and cell transforma-
tions. Single null mutants were obtained by using the short flanking homology
approach after PCR amplification of the kanMX4 (66) and the CaURA3MX (25)
cassettes. Disruptions were confirmed by PCR analysis. Multiple mutants were
obtained by crossing the parental mutant strains, followed by diploid sporulation,
tetrad analysis, and selection of the mutant combinations (60). For 3HA tagging
of the coding terminus of the chromosomal copies of GRX6 and GRX7, the
pYM24 plasmid was employed, using the hphNT1 cassette and selecting for
hygromycin B resistance (31).
Subcellular fractionation. Crude membrane fractions were prepared after
mechanical breakage of yeast cells in lysis buffer (0.1 M sorbitol, 50 mM potas-
sium acetate, 20 mM HEPES, pH 7.5, 2 mM EDTA, 1 mM dithiothreitol plus
protease inhibitors [2 mM phenylmethylsulfonyl fluoride, 0.2 mM tolylsulfonyl
phenylalanyl chloromethyl ketone, 2 M pepstatin A]) on ice. Cells debris was
removed by centrifugation (700  g, 5 min) and the supernatant was subjected to
different treatments for protein extraction for 1 h at 0°C as follows: 0.5 M NaCl,
2.5 M urea, 0.1 M Na2CO3 at pH 11.5, or 1% Triton X-100 plus 0.5 M NaCl.
Subsequently, the samples were separated into supernatant and pellet fractions
by centrifugation (100,000  g, 2 h) at 4°C.
Subcellular fractionation in 20 to 60% sucrose gradients was carried out in the
presence of either 2 mM MgCl2 or 10 mM EDTA. Essentially, cultured cells were
centrifuged; washed in 50 mM Tris-HCl buffer, pH 7.5, plus 10 mM sodium azide
and 10 mM potassium fluoride; and incubated for 20 min at 30°C in 50 mM
Tris-HCl buffer, pH 7.5, plus 0.5% 2-mercaptoethanol. After the cells were spun,
they were resuspended in protoplasting buffer (1.2 M sorbitol, 0.5 mM MgCl2, 40
mM HEPES, pH 7.5) plus Zymolyase 100T (2 mg per g of cells [dry weight]) and
incubated at 30°C until protoplast formation was almost complete (usually about
30 min). Protoplasts were collected by centrifugation (2,500  g, 5 min) at 4°C
and lysed by resuspension in STE10 buffer (10% sucrose, 10 mM Tris HCl, pH
7.5, 1 mM dithiothreitol, protease inhibitors, and either 2 mM MgCl2 or 10 mM
EDTA) followed by Dounce homogenization. Intact cells and large cell aggre-
gates were removed by centrifugation at 2,500  g for 2 min at 4°C. The resulting
supernatant was applied to the respective sucrose gradient containing either
MgCl2 or EDTA, and the subsequent steps were as described in reference 53.
Proteinase K protection assay. Cells expressing epitope-tagged proteins were
mechanically disrupted with glass beads in 0.7 M sorbitol in 50 mM Tris-HCl
buffer, pH 7.5. After elimination of unbroken cells and cell aggregates by cen-
trifugation (700  g, 5 min) at 4°C, the supernatant was left untreated or was
treated with proteinase K (0.1 mg/ml) or with proteinase K plus 1% Triton X-100
for 20 min at 0°C. After the addition of phenylmethylsulfonyl fluoride (final
concentration, 5 mM), proteins were precipitated with 15% trichloroacetic acid.
Pellets were solubilized for sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and Western blot analyses.
Western blotting. Western blot analyses were done as described in reference
2. The following primary antibodies were employed: 12CA5 mouse monoclonal
anti-hemagglutinin (HA) (dilution 1:2,500; Roche), M2 mouse monoclonal anti-
FLAG (1:1,500; Sigma), 5C5 mouse monoclonal anti-Dpm1 (1:2,000; Molecular
Probes), rabbit polyclonal anti-Emp47 (1:2,000 [59]), rabbit polyclonal anti-Hxk1
(1:5,000; USBiological), or 10A5 mouse monoclonal anti-carboxypeptidase Y
(CPY) (1:500; Molecular Probes).
Northern blotting. RNA electrophoresis, probe labeling with digoxigenin, hy-
bridization, and signal detection in a Lumi-Imager instrument (Roche Applied
Science) were done as described previously (2). Gene probes were PCR gener-
ated from genomic DNA, using oligonucleotides designed to amplify internal
open reading frame regions.
Immunofluorescence microscopy. Immunofluorescence colocalization of
Grx6-HA or Grx7-HA proteins and the green fluorescent protein (GFP)-fused
endoplasmic reticulum (ER) marker Ole1 was done as described in reference 65.
3F10 rat anti-HA (Roche) and Alexa555 goat anti-rat (Molecular Probes) anti-
bodies were employed for signal detection. Colocalization of Grx6-HA or
Grx7-HA and the Golgi marker Emp47 was done as described above, except that
incubations were sequentially made with the anti-Emp47 antibody in the pres-
ence of 0.1% Triton X-100 followed by the anti-HA antibody without detergent.
Emp47 signal was detected with rabbit anti-Emp47 (59) and Alexa485 goat
anti-rabbit (Molecular Probes) antibodies.
Determination of thiol oxidoreductase activity. Thiol oxidoreductase (glutare-
doxin) activity was measured with HEDS as the substrate, as described previously
(29), using extracts from exponential cells after mechanical disruption and the
elimination of unbroken cells and aggregates by centrifugation (700  g, 5 min)
at 4°C.
In vivo labeling with 55Fe and protein immunoprecipitation. In vivo labeling of
yeast cells with 55FeCl and analysis of iron binding to HA-tagged proteins by
immunoprecipitation and scintillation counting was done as described in refer-
ence 42. F7 mouse monoclonal anti-HA antibodies (Santa Cruz) were used for
immunoprecipitations.
RESULTS
Putative membrane-associated monothiol Grxs exist in di-
verse fungal species. S. cerevisiae Grx6 and Grx7 proteins have
a Grx module with an N-terminal extension that includes a
putative TM domain (see Fig. S1A in the supplemental mate-
rial). The Grx module displays a high degree of homology with
S. cerevisiae Grx1 and Grx2 and with other dithiol Grxs (39,
40). However, the active-site sequences of both monothiol
Grxs (CSYS for Grx6 and CPYS for Grx7) differ from the
active sites of dithiol Grxs. A BLAST analysis based on the Grx
modules of Grx6 and Grx7 revealed that homologues of these
two proteins exist only in fungi, some plants, and worms. They
share the following sequence, which includes the active site:
I/VF/YSKS/TXCP/SXS. Two subtypes can be established
based on the alternative amino acid (S or P) adjacent to the
active-site cysteine (see Table S1 in the supplemental mate-
rial). The Saccharomyces sensu stricto species contain one
member of each subtype, while other organisms, including the
multicellular ones, contain a single member. When a phyloge-
netic tree was constructed based on multiple alignment of the
sequences listed in Table S1 in the supplemental material,
several clusters that resembled the phylogenetic groups
were generated (see Fig. S1B in the supplemental material).
Thus, the Ascomycetae, Euascomycetae, and Basidiomycetae
sequences became grouped separately from each other.
Among the Saccharomyces sensu stricto species, two subgroups
were generated, represented by S. cerevisiae Grx6 and Grx7,
respectively. Most fungal sequences contain the N-terminal
extension with the putative TM domain (see Table S1 and Fig.
S1B in the supplemental material). On the contrary, the worm
and plant homologues are shorter and lack this domain. In
summary, monothiol Grxs with a putative TM domain seem
characteristic for fungi, although TM-less relatives exist in
other organisms.
Grx6 and Grx7 localize at membranes of secretory vesicles.
Initially, we intended to obtain Grx6 and Grx7 derivatives
tagged with GFP at the C termini in order to determine the
cellular locations of both proteins in vivo. While the corre-
sponding GFP constructions were obtained for Grx7, this was
not possible for Grx6, even with other GFP-derived fluorescent
tags. As an alternative, we marked Grx6 and Grx7 with the HA
tag at the respective C termini by use of integrative plasmids.
Several forms with slightly different gel mobilities were ob-
served in the case of Grx6, and this was also the case for Grx7,
although less prominently (Fig. 1; also see below). The respec-
tive Grx-HA strains were employed for sucrose gradient cen-
trifugation analyses in the presence of Mg2 or EDTA to
differentiate between ER and Golgi membranes (Fig. 1, left).
Grx6 distributed in fractions that overlapped with the dis-
tribution of ER (Dpm1) and Golgi (Emp47) markers in
EDTA-containing gradients. In Mg2 gradients, part of the
Grx6 protein shifted to denser fractions corresponding to
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ribosome-associated microsomes, together with Dpm1, while an-
other part remained in fractions cosedimenting with Emp47. In
contrast, Grx7 sedimented in fractions containing the Golgi
marker Emp47 in both Mg2 and EDTA gradients (Fig. 1, right).
The above observations are consistent with a distribution of
Grx6 between ER and Golgi vesicles, while Grx7 would be
mostly if not entirely located at the site of the Golgi apparatus.
This confirms the study of Mesecke et al. (40), which also
involved membrane subfractionation to demonstrate that Grx7
is located at Golgi vesicles. However, the present study extends
these observations to indicate that in addition to fractionation
to the Golgi, Grx6 also fractionates at ER membranes. To
support the subfractionation analysis results, we carried out
immunofluorescence studies with the Grx6-HA and Grx7-HA
strains by use of anti-HA antibodies. Grx6 showed a perinu-
clear fluorescence pattern as well as a dotted distribution,
while Grx7 mostly displayed a dotted distribution (Fig. 2A).
With Ole1-GFP and Emp47 being used as markers for ER and
Golgi compartments, respectively, the Grx6 perinuclear pat-
tern overlapped with that of Ole1, while the Grx6 dotted dis-
tribution overlapped with Emp47 fluorescence (Fig. 2B). This
dotted pattern is characteristic of Golgi proteins (59). It is
important to remark that the analyses were done with cells that
expressed GRX6 under its own promoter. When cells were
overloaded with Grx6 protein expressed from a multicopy plas-
mid, the perinuclear staining was predominant (not shown).
Thus, immunofluorescence confirmed a distribution of Grx6
between the ER and Golgi compartments in physiological con-
ditions. The dotted fluorescence of Grx7 also overlapped with
Emp47 (Fig. 2B), confirming the predominant location of this
protein in the Golgi apparatus. These patterns were not ob-
served when Grx6 and Grx7 derivatives that lacked the TM
domain deletions were analyzed (	3-40 and 	3-36, respec-
tively). These were localized in the entire cytoplasm (Fig. 2C).
This observation emphasizes the importance of the domain for
the membrane vesicle-associated distribution of Grx6 and
Grx7.
In order to determine the membrane topology of Grx6 and
Grx7, we obtained high-speed centrifugation microsomal frac-
tions from cells expressing the respective HA derivatives, and
these fractions were subjected to salt, carbonate (pH 11.5),
urea, or Triton/salt treatments on ice. Only the last treatment
was able to extract Grx7 partially (Fig. 3A), which indicates
that Grx7 is most likely an integral membrane protein, as
shown in a previous study (40). Grx6 was not extracted at all
under these conditions, even in the presence of the detergent.
We had to employ stronger extraction conditions (presence of
the detergent during cell lysis) to partially release Grx6 from
the membranous vesicle fraction (Fig. 3B). Therefore, Grx6
FIG. 1. Analysis of the association of Grx6 and Grx7 to membrane fractions. Exponentially growing cells (about 3  109) in YEPD medium
carrying a chromosomally integrated GRX6-3HA (MML897, left) or GRX7-3HA (MML999, right) fusion were employed for obtention of total cell
extracts, which were clarified by low-speed centrifugation. The supernatant (fraction T) was subjected to 20% to 60% sucrose gradient centrifu-
gation (5.5-ml total volume of the gradient) in the presence of 2 mM MgCl2 or 10 mM EDTA. Each of the 12 resulting fractions was subjected
to Western blot analysis to determine the distribution of Grx6-HA or Grx7-HA, Dpm1 (ER marker), Emp47 (Golgi marker), or Hxk1 (cytosolic
marker), by use of adequate antibodies. Ten microliters from each fraction was analyzed in each lane, except for the lane for fraction T, which
corresponds to 25 g of total protein. The relative distribution of total protein along the fractions is also indicated.
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seems to be more strongly anchored at membranes than is
Grx7.
Having shown that Grx6 and Grx7 are integral membrane
proteins, we carried out proteinase K protection assays using
Sec62-FLAG (integral ER membrane protein facing the cy-
tosol) and Kar2-FLAG (luminal ER protein) as controls. Grx6
and Grx7 exhibited digestion patterns identical to that seen for
Kar2 and contrary to that for Sec62; that is, they were pro-
tected from proteinase K digestion unless the membranes were
permeabilized with Triton (Fig. 3C). We conclude that both
Grx6 and Grx7 are integral membrane proteins with the glu-
taredoxin domain facing the vesicle lumen.
GRX6 and GRX7 expression is induced under diverse stress
conditions. Analysis of the respective promoter sequences re-
vealed a calcineurin-dependent response element in the GRX6
promoter, while the GRX7 promoter contains a stress response
element (STRE) (Fig. 4A). In S. cerevisiae, the calcineurin-
dependent response element sequence is recognized by the
Crz1 transcription factor, whose nucleocytoplasmic location
and consequent transcriptional activity are under the control of
the calcineurin phosphatase pathway (15, 41). This pathway is
activated under specific stress conditions, such as exposition to
high levels of Ca2 or Na, heat shock, or incubation with
-factor (70). The STRE is recognized by the Msn2/Msn4
transcription factor, which mediates a general environmental
stress response in yeast cells upon exposition to heat, oxidative,
and osmotic shocks among others (18). The presence of the
respective response elements in the GRX6 and GRX7 promot-
ers suggested that these two genes could respond to a number
of external stresses. To test this hypothesis, we analyzed the
expression levels of GRX6 and GRX7 under several stress
conditions. Neither of the two genes responded to heat (25 to
37°C) or osmotic (1 M sorbitol) stress or to nutrient depriva-
tion under postdiauxic growth conditions (data not shown). In
contrast, GRX6 expression was modestly upregulated by cal-
cium, sodium, and oxidative stresses (Fig. 4B). In a Crz1-
deficient mutant, such upregulation was partially eliminated,
especially during sodium stress. The absence of Msn2/4 also
negatively affected the induction of GRX6 expression by those
three stresses, probably indirectly, since the GRX6 promoter
does not contain STREs. Sodium and oxidative stresses, but
not calcium stress, caused modest upregulation of GRX7 ex-
pression. In this case, it was dependent on Msn2/Msn4 but not
on Crz1 (Fig. 4B). We conclude that the Crz1-calcineurin
pathway (for GRX6) and the Msn2/Msn4 factors (for GRX7)
directly regulate the activation of these GRX genes after
exposition to a specific set of stress conditions.
Next, we determined how the above-mentioned stresses in-
FIG. 2. Immunolocalization of Grx6 and Grx7. (A) Exponentially growing cells in YEPD medium and carrying a chromosomally integrated
GRX6-3HA (MML897) or GRX7-3HA (MML999) fusion were analyzed by immunofluorescence with anti-HA antibodies. Nuclei were detected by
DAPI (4,6-diamidino-2-phenylindole) staining. (Right) Wild-type (W303-1A) cells treated with anti-HA antibodies. (B) Strains MML897 and
MML999 were analyzed by immunofluorescence for colocalization of Grx6 or Grx7 and the Golgi marker Emp47 by use of anti-HA and
anti-Emp47 antibodies (right). Similarly, derivatives of the above-mentioned strains that also carried a chromosomal Ole1-GFP fusion as an ER
marker (MML1001 for the GRX6-HA strain and MML1003 for the GRX7-HA strain) were analyzed for colocalization, using anti-HA antibodies
and GFP fluorescence analysis (left). Nuclei were detected by DAPI staining. (C) Cells expressing partially deleted versions of HA-tagged Grx6
(	3-40; strain MML1037) or Grx7 (	3-36; strain MML10399) were analyzed for immunolocalization with anti-HA antibodies. DAPI staining is
also shown.
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fluence the levels of the Grx6 and Grx7 proteins. Calcium and
sodium stresses did not significantly affect the amount of Grx6
(Fig. 5A). However, there was a temporary enrichment in the
relative amount of the lower-mobility Grx6 forms, to return to
the original situation at late times. Upon exposition to ter-butyl
hydroperoxide (t-BOOH), there was a temporary increase of
total Grx6 protein and a sustained accumulation of the low-
mobility bands. Although 1 M sorbitol did not upregulate
GRX6 expression (Fig. 4B) and did not increase protein levels
(Fig. 5A), after 20 min of osmotic stress almost all the Grx6
protein had been converted into lower-mobility species, to
recover to basal conditions after 80 min. We also tested the
effect of calcium or sodium stresses on Grx7 (Fig. 5A). In
accordance with the kinetics of GRX7 expression, Grx7 levels
did not increase upon exposition to a high level of calcium (in
fact, the protein amounts decreased at late time points), while
sodium stress caused a large accumulation of Grx7. It should
be noted that the Western blot of sodium-treated Grx7-HA
cells shown in Fig. 5A was less exposed than were those in
other cases; therefore, basal levels cannot be compared with
those in other experiments. In those cases when Western blots
were overexposed, such as for calcium-treated Grx7-HA cells,
some lower-mobility Grx7 bands could also be observed (Fig.
5A). No changes in the cellular locations of Grx6 and Grx7
under calcium, sodium, oxidative, and osmotic stresses were
appreciated during immunolocalization experiments (data not
shown).
In order to determine whether the heterogeneity of Grx6
and Grx7 depends on their membrane-associated location, we
subjected yeast cells carrying the HA-tagged wild-type proteins
or the derivatives lacking the respective TM domains to sor-
bitol stress. Both TM-deleted Grx6 and Grx7 forms extracted
from untreated cells migrated as sharp single bands in gels, and
no lower-mobility bands appeared due to stress (Fig. 5B).
Therefore, the extensive modification of Grx6 and, to a lesser
extent, also of Grx7 occurs only in the membrane-associated
forms.
We focused our attention on Grx6 to determine the type of
modification affecting protein mobility in gels. Neither shrimp
alkaline nor lambda phosphatase treatments affected the mi-
gration of immunoprecipitated Grx6-HA protein (not shown),
strongly indicating that phosphorylation was not involved. We
then tested whether interfering with the ER/Golgi partition of
Grx6 affected the extent of sorbitol-induced protein modifica-
tion by using a temperature-sensitive sec18 strain that accumu-
lates ER membrane vesicles at 37°C. In fact, at the restrictive
temperature Grx6 was modified only to a minor extent (Fig.
5C), while full modification occurred in the wild-type strain at
37°C (not shown). These observations indicated that extensive
modification of Grx6 upon sorbitol treatment required move-
ment into Golgi membranes. Many yeast proteins associated
with the secretory machinery are subjected to N- or O-linked
glycosylation. The ER and Golgi location of Grx6 suggested
that the protein modification could be glycosylation. The fact
FIG. 3. Membrane topology of Grx6 and Grx7. (A) Extracts from exponentially growing cultures in YEPD (1.5  109 cells) of MML897
(GRX6-3HA) and MML999 (GRX7-3HA) strains were divided into five aliquots, which were treated (at 0°C) with buffer or buffer plus 0.5 M NaCl,
2.5 M urea, 0.1 M Na2CO3 (pH 11.5), or 1% Triton X-100 plus 0.5 M NaCl followed by high-speed centrifugation for separation into pellet (P) and
supernatant (S) fractions. These were analyzed by Western blotting with anti-HA antibodies. Each line corresponds to the protein equivalent of
5  107 cells. (B) Western blot of extracts from MML897 cells which were obtained after breaking the cells as described for panel A, except that
0.5 M NaCl or 1% Triton X-100 plus 0.5 M NaCl was present in the lysis buffer. Cell lysis was immediately followed by high-speed centrifugation
to separate into pellet and supernatant fractions. (C) Extracts from exponentially growing cultures in YEPD (1.5  109 cells) of MML1013
(GRX6-3HA KAR2-6FLAG), MML1014 (GRX6-3HA SEC62-6FLAG), MML1011 (GRX7-3HA KAR2-6FLAG), and MML1012 (GRX7-3HA
SEC62-6FLAG) strains were divided into three aliquots, which were mock treated or treated with proteinase K in the presence or absence of Triton
X-100. Proteins were precipitated and analyzed by Western blotting with anti-HA antibodies.
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that tunicamycin (an inhibitor of N-linked glycosylation) still
induced changes in Grx6 gel mobility (see below) ruled out this
type of glycosylation as a source of Grx6 heterogeneity. On the
other hand, in yeast cells O-linked glycosylation of Ser or Thr
residues begins at the ER by the addition of a single mannose
unit and continues at the Golgi by the addition of up to four
additional mannose units (61). A family of ER O-mannosyl-
transferases coded by the PMT1 to -6 genes is involved in the
addition of the first mannose residue, with partial substrate
specificity (22). We therefore tested sorbitol-induced modifi-
cation in different 	pmt mutants that expressed the Grx6-HA
protein. In the genetic background employed (BY4741), Grx6
displayed a higher degree of modification than in other back-
grounds in basal untreated conditions (Fig. 5D). In any case, a
	pmt2 mutant had mostly inhibited the modification of Grx6
both before and after sorbitol treatment (Fig. 5D). The mod-
ification of Grx6 was also partially inhibited in a 	pmt1 mutant,
although to a lesser extent. The above results suggest that the
modification of Grx6 consists of the addition of O-linked sac-
charides at the ER and Golgi compartments.
ER stress causes accumulation of Grx6 and Grx7 proteins.
ER stress is provoked by situations leading to the accumulation
of unfolded proteins at the lumen of this organelle, for instance
after treatment with the reducing agent dithiothreitol or the
N-linked glycosylation inhibitor tunicamycin. In these condi-
tions, the unfolded protein response (UPR) is induced to up-
regulate secretory pathway functions and to enhance protein
refolding (49, 58). Thus, genes involved in disulfide bond for-
mation, in chaperone activity, and in N- and O-linked glyco-
sylation participate in the UPR in S. cerevisiae (62). However,
tunicamycin also induces an UPR-independent response me-
diated by calcineurin (5). We determined whether ER stress
due to tunicamycin affected the expression of GRX6 and
GRX7. Northern analyses demonstrated that both genes were
upregulated upon ER stress (Fig. 6A). The induction of GRX6
was partially dependent on Crz1, and a minor (probably indi-
rect) dependence on Msn2/Msn4 was also observed. In con-
trast, the induction of GRX7 expression was significantly re-
duced in the absence of Msn2/Msn4, while it did not depend on
Crz1 (Fig. 6A). In parallel, tunicamycin treatment caused a
FIG. 4. Northern blot analysis of the expression of GRX6 and
GRX7. (A) Structure of the GRX6 and GRX7 promoters. CDRE,
calcineurin-dependent response element. (B) Expression of GRX6 and
GRX7 after the addition of 0.2 M CaCl2, 0.6 M NaCl, or 1 mM
t-BOOH. Cells from wild-type (W303-1A) and the respective isogenic
	crz1 (MML871) and 	msn2 	msn4 (Wmsn2msn4) strains were
grown exponentially in YEPD medium. When cultures reached a con-
centration of 1.5  107 cells per ml, the agent was added at the
indicated concentration (time zero), and samples were obtained at the
indicated times for expression analysis. A total of 25 g of total RNA
was run per lane. U1 RNA was used to confirm that all lanes were
equally loaded.
FIG. 5. Effect of several stresses on Grx6 and Grx7 proteins.
(A) Cells of the MML953 (GRX6-3HA::hphNT1) and MML949
(GRX7-3HA::hphNT1) strains growing exponentially in YEPD me-
dium were treated at the indicated times with 0.2 M CaCl2, 0.6 M
NaCl, 1 mM t-BOOH, or 1 M sorbitol. Total cell extracts (20 g
protein per lane) were subjected to Western blot analysis with anti-HA
antibodies. (B) The following strains growing exponentially in YEPD
medium were subjected to 1 M sorbitol treatment for 30 min and
analyzed by Western blotting (20 g total cell protein per lane) with
anti-HA antibodies: MML897 (expressing wild-type Grx6-HA),
MML1037 (	3-40 Grx6 deletion), MML999 (wild-type Grx7-HA), and
MML1039 (	3-36 Grx7 deletion). (C) MML1010 cells (sec18ts GRX6-
3HA) were grown exponentially at 25°C in YEPD and treated with 1 M
sorbitol for 30 min. A fraction of the culture was shifted to 37°C and,
after 2 h, was also subjected to sorbitol treatment. Samples were taken
for Western blot analysis (20 g total cell protein per lane) with
anti-HA antibodies. (D) Wild-type BY4741 cells or pmt mutant deriv-
atives (Y03792 [	pmt1], Y00385 [	pmt2], Y01618 [	pmt3], Y03790
[	pmt5], Y04829 [	pmt6]) transformed with pMM892 (centromeric
plasmid expressing GRX6-3HA under its own promoter) were grown
exponentially in SC medium and subjected to 1 M sorbitol treatment
for 30 min. Samples were analyzed by Western blotting (20 g total cell
protein per lane) with anti-HA antibodies.
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dramatic increase in the amount of Grx6 and Grx7 proteins,
especially of the more extensively O-glycosylated forms (Fig.
6B). All these observations established a relationship between
Grx6/Grx7 and ER stress.
Mutants deficient in Grx6 and Grx7 show moderate resis-
tance to tunicamycin. We tested the sensitivities of the single
	grx6 and 	grx7 mutants and the double mutant to some of the
agents that upregulated expression of GRX6 and GRX7. How-
ever, none of the mutants displayed differential sensitivity (rel-
ative to wild-type cells) to CaCl2, NaCl, or t-BOOH (data not
shown). Also, the mutants did not exhibit significant differ-
ences with respect to sensitivity to diamide, high temperature
(37°C), alkaline conditions (pH 8), cadmium, osmotic stress by
KCl, or dithiothreitol. In a previous study (40), a mutant lack-
ing Grx6 was hypersensitive to hydrogen peroxide, while the
absence of any amount of either Grx caused growth defects at
37°C. These discrepancies can be caused by the different ge-
netic backgrounds employed in both studies. However, under
our conditions the single and double mutants displayed a mod-
erate resistance to tunicamycin (Fig. 6C). This effect was not
due to the drug being unable to act at the ER environment of
the mutants, since it was still able to inhibit the N glycosylation
of CPY in the single and double mutants (Fig. 6D). Since the
induction of the protein kinase C pathway in S. cerevisiae and
the consequent activation of the Slt2 mitogen-activated kinase
leads to tunicamycin resistance (9), we analyzed whether Slt2
was constitutively activated in the mutants. However, this was
not the case (data not shown). Nevertheless, these results con-
firm a functional relationship between ER stress and Grx6/
Grx7 (see Discussion).
Grx6 and Grx7 display thiol oxidoreductase activity in vivo.
Grx6 and Grx7 have been shown to possess thiol oxidoreduc-
tase activity in vitro (39, 40). To demonstrate that both pro-
teins also display such activity under physiological conditions,
we constructed two strains that overexpressed Grx6 and Grx7,
respectively, in a genetic background that lacked the standard
dithiol glutaredoxins Grx1 and Grx2. Extracts from such yeast
cells had thiol oxidoreductase activity significantly higher than
that seen for control cells, and this activity increased between
1.5- and 2-fold after tunicamycin treatment (Fig. 7A). On the
contrary, the overexpression of mutant forms of GRX6 or
GRX7 in which the active-site cysteine residues had been
changed to serine did not increase the thiol oxidoreductase
activity over background levels (data not shown). These results
confirmed that the enzyme activity of Grx6 and Grx7 is present
in vivo and that it parallels the increase of protein levels during
the ER stress due to tunicamycin. Significantly, extracts over-
expressing Grx7 had higher activity than those overexpressing
Grx6 (Fig. 7A), in accordance with results from reference 40,
indicating that purified Grx7 is more active in HEDS assays
than is Grx6. Next, we determined whether conditions (1 M
sorbitol treatment) that induce over-O-glycosylation of Grx6
cause changes in the in vivo activity of the protein without
affecting total protein levels. However, thiol oxidoreductase
activity levels remained approximately constant during the
osmotic stress by sorbitol (Fig. 7B), demonstrating that the activ-
ity is not affected by the modification of the protein in these
conditions.
FIG. 6. Relationship between tunicamycin (TN)-induced ER stress and Grx6/Grx7. (A) Northern analysis of GRX6 and GRX7 expression after
the addition of TN (0.75 g/ml, time zero) to cells from wild-type (W303-1A) and the respective isogenic 	crz1 (MML871) and 	msn2 	msn4
(Wmsn2msn4) strains growing exponentially in YEPD medium. Samples were obtained at the indicated times for expression analysis. A total of
25 g of total RNA was run per lane. (B) Western blot analysis of Grx6-HA and Grx7-HA levels in cells from strains MML953
(GRX6-3HA::hphNT1) and MML949 (GRX7-3HA::hphNT1) expressing the respective tagged chromosomal genes. Exponential cells in YEPD
medium were treated for 4 h with the indicated TN concentration before Western blot analysis of total cell extracts (20 g per lane) with anti-HA
antibody. (C) Sensitivity of W303-1A, MML890, MML887, and MML892 cells to TN in YEPD plates after 3 days of incubation (1:10 serial
dilutions of exponential cultures) at 30°C. (D) Western blot of CPY for exponentially growing W303-1A, MML890, MML887, and MML892 cells
untreated or treated for 4 h with TN at 0.5 g/ml. The mobilities of N-glycosylated (band a) and non-N-glycosylated (band b) forms are indicated.
FIG. 7. In vivo thiol oxidoreductase activity of Grx6 and Grx7.
(A) Enzyme activity (expressed as nmol/min/mg total cell protein) in
MML752 (	grx1 	grx2) cells transformed with the YEplac195 vector
or the multicopy plasmid derivatives pMM822 (GRX6 expression) and
pMM763 (GRX7 expression) and growing exponentially in SC me-
dium. Gray and black bars correspond to untreated and tunicamycin
(0.5 g/ml, 2 h)-treated cultures, respectively. Values over bars are the
means from three experiments. (B) Enzyme activity in pMM822-trans-
formed MML752 cells growing exponentially in SC medium and
treated with 1 M sorbitol for the indicated times. Values are the means
from three experiments.
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Grx6 binds iron in vivo. Monothiol Grxs including Grx6
harbor a Fe/S cluster cofactor upon recombinant expression in
Escherichia coli (39). We have confirmed that observation and
also that recombinant Grx7 does not contain such a cluster. In
order to analyze whether Grx6 binds iron in S. cerevisiae in
vivo, a HA-tagged version of Grx6 was overexpressed in wild-
type cells from the high-copy-number vector pMM866 under
the control of its own promoter. Cells were grown in iron-poor
SD medium (60) for 16 h and radiolabeled with 55Fe for 2
hours. Whole-cell lysates were prepared under anaerobic con-
ditions, and Grx6 was immunoprecipitated with anti-HA anti-
bodies. The amount of 55Fe bound to the immunobeads re-
flects the amount of iron bound to Grx6 and was quantified by
scintillation counting (Fig. 8A). A rather small but significant
amount of radioactive 55Fe (
1 pmol 55Fe/g cells) coprecipi-
tated with anti-HA antibodies from cells overproducing Grx6-
HA. Only background levels of radioactivity (0.4 pmol 55Fe/g
cells) were detected when we used cells that did not contain
Grx6-HA or that overproduced the site-directed mutant that
carried a C136S mutation in the conserved active-site cysteine
of Grx6. Iron association to Grx6-HA declined to background
levels upon incubation of the immunoprecipitated protein with
EDTA (Fig. 8B). Taken together, these results demonstrate
that Grx6 binds iron with low affinity in a labile fashion at its
active-site cysteine when overproduced in yeast cells. However,
the low affinity of Grx6 for iron precluded any attempts to
determine whether the iron is bound in form of a Fe/S cluster
on Grx6 in vivo.
DISCUSSION
Eukaryotic Grxs are present in such different compartments
as the cytosol, nucleus, mitochondria, and chloroplasts, carry-
ing out a diverse array of functions as regulators of thiol redox
state (19, 28). Here we describe two S. cerevisiae monothiol
Grxs located at the ER and/or Golgi membranes and facing the
luminal side of the vesicles. Homologues of these two Grxs
with similar structures exist in different fungal groups. A
Schizosaccharomyces pombe homologue of Grx6/Grx7 which
also manifests the perinuclear distribution of ER proteins has
been described previously (12).
Is the lumen of secretory vesicles adequate for the enzyme
activity of Grx6 and Grx7? The ER lumen is an oxidizing
environment which favors the activity of protein disulfide
isomerase (PDI) in the formation of native disulfide bonds in
proteins of the secretory pathway. Among the large number of
species of the PDI family in human cells, four of them are ER
membrane associated, facing the vesicle lumen (17). In the ER
lumen, reactive oxygen species are generated mostly as a side
effect of the action of Ero1 thiol oxidase on its substrate, PDI
(26). This is in accordance with the observation that the ratio
between GSH and oxidized glutathione is much lower in the
lumen of secretory vesicles than in the cytosol (30) and that a
majority of glutathione molecules in ER microsomes exist as
mixed disulfides with resident proteins (1). While protein glu-
tathionylation can be contemplated as a mechanism for tem-
porary protection against the irreversible oxidation of cysteine
residues, the restoration of native sulfhydryl groups is a pre-
requisite for protein functionality. PDI is able to carry out the
deglutathionylation reaction concomitantly with the formation
of native disulfide bonds (8). Grx6 or Grx7 could also be able
to catalyze this reaction and thus to regulate the redox state of
protein sulfhydryl groups in the lumen of the ER/Golgi. In fact,
the monothiol mechanism of action of Grxs involves resolving
mixed disulfides between GSH and protein sulfhydryls in a
process that requires a single reduced cysteine in the Grx
molecule and results in a mixed disulfide between GSH and
Grx (6). GSH is subsequently required for the reduction of the
mixed disulfide and the regeneration of the active enzyme. The
question remains whether GSH could act as such a Grx reduc-
tant in the oxidizing environment of the ER. GSH could be
generated by the action of PDI at the ER lumen (8). Also, in
yeast cells, the depletion of GSH rescues the phenotypic de-
fects of an ero1 mutant caused by excessive PDI reduction,
FIG. 8. Grx6 binds iron in vivo. (A) Wild-type cells and cells over-
expressing wild-type (wt) Grx6-HA and the C136S mutant from plas-
mids pMM866 and pMM880, respectively, were grown overnight in
iron-free SC medium containing glucose. Cells were labeled with 10
Ci 55Fe for 2 h. Cells were harvested, washed, and transferred to an
anaerobic chamber. Cells were resuspended in anaerobic Tris-buffered
saline–Tween buffer, and crude cell extracts were prepared by lysis
with glass beads. Grx6 was immunoprecipitated from extracts with
anti-HA antiserum under anaerobic conditions and the level of coim-
munoprecipitated radioactivity was quantified by scintillation counting.
The total amount of Grx6 in the extracts was assessed by immuno-
staining. Por1p was used as a loading control. (B) Wild-type cells and
cells overexpressing wild-type Grx6-HA were radiolabeled with 55Fe,
and Grx6 was immunoprecipitated with anti-HA antibodies as de-
scribed above. Following the sedimentation of the immunobeads, the
beads were washed three times with buffer either lacking EDTA () or
supplemented with 2.5 mM EDTA () under anaerobic conditions.
Error bars indicate the standard deviations of the measurements.
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which led to the interpretation that GSH can act as a net
reductant in the ER (14). Notably, E. coli Grx1 is able to act as
a disulfide oxidase in in vitro assays, using the monothiol mech-
anism more efficiently than PDI (69). In in vitro assays, Grx7
has no protein-refolding activity (40). This requires disulfide
reduction in addition to sulfhydryl oxidation and is character-
istic of PDI enzymes. Nevertheless, there is a possibility that
Grx6 and Grx7 carry out the deglutathionylation of GSH-
mixed disulfides concomitantly with disulfide bond formation
in the oxidant environment of the early secretory pathway.
Although Grx6 and Grx7 are structurally similar, there are a
number of differences that point to at least partially different
cellular functions. First, recombinant Grx6 is a Fe/S protein
while Grx7 is not, which is an effect of the active-site differ-
ences that exist among them (3, 39, 57). Another difference
concerns their cellular distributions, namely, ER and Golgi for
Grx6 and Golgi for Grx7. This asymmetric distribution may
explain their differences in O-glycosylation pattern, which is
more extensive in Grx6, even in unstressed cells. Saccharide
chain extension begins at the ER with a first mannose unit to
continue at the Golgi (61), with ER-located complexes be-
tween Pmt1 and Pmt2 playing a main role in substrate recog-
nition and the addition of the first mannose (24). Pmt2 and (to
a minor extent) Pmt1 are responsible for initiating the O gly-
cosylation of Grx6. We do not know whether there is an ER
and Golgi recycling of Grx6 molecules or whether there are
permanent subpopulations at both compartments, although in
any case the ER Grx6 pool would become prone to O-mannose
modification at some of the 24 serine or 11 threonine residues
of the molecule and to eventual chain extension when reaching
the Golgi membranes.
Grx6 and Grx7 also differ with respect to transcriptional
regulation in response to a number of stresses and the tran-
scription factors involved. The modest upregulation of GRX6
expression in response to calcium, sodium, and oxidative
stresses depends in part on the Crz1-calcineurin pathway. In
response to calcium and sodium, this pathway regulates the
expression of genes that participate in transport of small mol-
ecules, ion homeostasis, cell wall synthesis and remodeling, or
vesicle transport (70), that is, in functions which in many cases
can be related to secretory compartments. At the protein level,
among those stresses only oxidative stress caused a transient
increase in amount of Grx6. However, temporary accumula-
tion of the most O-glycosylated forms occurred after the stress.
There are no previous reports on the increment of activity of
the Pmt proteins after such stress conditions. We can hypoth-
esize that the transient increase of the extensively O-glyco-
sylated forms may be due to transient protein accumulation in
the ER, which we have not been able to detect microscopically.
The response of GRX7 expression to the indicated stresses is
more modest than that of GRX6 and seems to be part of the
Msn2/4-mediated environmental stress response. However,
among all the conditions tested, sodium ion stress resulted in
the most intense Grx7 response. A different situation is the
response of GRX6 and GRX7 to ER stress by tunicamycin.
Both genes are upregulated under such a condition, in man-
ners dependent on Crz1 and Msn2/4, respectively, and this is
paralleled by protein accumulation. Tunicamycin provokes two
kinds of responses in yeast cells: the Ire1- and Hac1-mediated
UPR for protein refolding (62) and the Pkc1/Slt2 and cal-
cineurin/Crz1-mediated response for cell survival (4, 5). GRX6
and GRX7 seem to respond only to the Crz1 pathway, as
neither of these genes have been described as UPR targets in
two independent studies (34, 62).
What could be the function of Grx6 and Grx7 at the secre-
tory apparatus? They do not seem to play a general role in
protein N glycosylation and/or folding, as (i) a reporter pro-
tein, CPY, is correctly N glycosylated in cells lacking one or
both Grxs (this work); and (ii) the UPR is not constitutively
induced in either the single or the double mutant (40). The
mutants, however, behave similarly with respect to their in-
creased resistance to tunicamycin. Previous observations re-
lated redox regulation, oxidative stress, and tunicamycin resis-
tance in yeast cells. A mutant lacking cytosolic thioredoxin
reductase (Trr1) is hyperesistant to tunicamycin, while a dou-
ble mutant in the two cytosolic thioredoxins is not (63). This
suggests a connection between tunicamycin stress and some
targets of Trr1 other than thioredoxins. On the other hand,
Eos1 is an ER membrane protein whose absence causes hy-
persensitivity to oxidative stress, tolerance to growth inhibition
by tunicamycin, and resistance to the N-glycosylation-inhibi-
tory effect of the drug (46). The Eos1 primary sequence, how-
ever, does not allow this protein to be associated with specific
biochemical functions. In the case of the grx6 and grx7 mutants,
the drug remains active as an N-glycosylation inhibitor of spe-
cific secretory proteins such as CPY. N-glycosylation defects or
ER stress caused by tunicamycin (in combination with temper-
ature increase to 37°C) induces apoptotic effects in yeast cells
(27). ER stress also induces apoptosis in mammalian cells (11,
16). Grx6 and Grx7 could be regulating the redox state of
cysteine residues required for the activity of specific proteins in
the ER or Golgi compartments, some of which could be re-
quired as intermediates in the cascade inducing apoptosis.
Since Grx6 and Grx7 are restricted to fungal membranes, such
regulatory functions in the membranes of the secretory vesi-
cles, if conserved, should be carried in higher eukaryotes by
other thiol oxidoreductases, such as some of the PDI species.
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